Tessema M - Search Results

1

Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.

Bock O, Tessema M, Serinsöz E, von Wasielewski R, Büsche G, Kreipe H. Bock O, et al. Among authors: tessema m. Leuk Res. 2004 Nov;28(11):1145-51. doi: 10.1016/j.leukres.2004.03.009. Leuk Res. 2004. PMID: 15380337

2

Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.

Länger F, Stickel J, Tessema M, Kreipe H, Lehmann U. Länger F, et al. Among authors: tessema m. Leuk Res. 2004 Oct;28(10):1081-3. doi: 10.1016/j.leukres.2004.01.020. Leuk Res. 2004. PMID: 15289021

3

Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.

Tessema M, Länger F, Bock O, Seltsam A, Metzig K, Hasemeier B, Kreipe H, Lehmann U. Tessema M, et al. Int J Oncol. 2005 Feb;26(2):499-507. Int J Oncol. 2005. PMID: 15645136

4

Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML).

Tessema M, Länger F, Dingemann J, Ganser A, Kreipe H, Lehmann U. Tessema M, et al. Leukemia. 2003 May;17(5):910-8. doi: 10.1038/sj.leu.2402891. Leukemia. 2003. PMID: 12750705

5

Cell cycle and no end.

Tessema M, Lehmann U, Kreipe H. Tessema M, et al. Virchows Arch. 2004 Apr;444(4):313-23. doi: 10.1007/s00428-003-0971-3. Epub 2004 Feb 17. Virchows Arch. 2004. PMID: 14968363 Review.

6

Nephroblastomatosis and loss of WT1 expression associated with trisomy 13.

Traub F, Sickmann K, Tessema M, Wilkens L, Kreipe HH, Kamino K. Traub F, et al. Among authors: tessema m. Virchows Arch. 2006 Feb;448(2):214-7. doi: 10.1007/s00428-005-0067-3. Epub 2005 Sep 22. Virchows Arch. 2006. PMID: 16177880

7

Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.

Tessema M, Yingling CM, Picchi MA, Wu G, Liu Y, Weissfeld JL, Siegfried JM, Tesfaigzi Y, Belinsky SA. Tessema M, et al. J Thorac Oncol. 2015 Aug;10(8):1181-8. doi: 10.1097/JTO.0000000000000592. J Thorac Oncol. 2015. PMID: 26200272 Free PMC article.

8

Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer.

Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X, Li Q, Zheng X, Saxton B, Chen W, Willink R, Li Z, Zhang L, Belinsky SA, Wang X, Zhou B, Lin Y. Wang Q, et al. Among authors: tessema m. Transl Oncol. 2020 Feb;13(2):372-382. doi: 10.1016/j.tranon.2019.11.011. Epub 2019 Dec 27. Transl Oncol. 2020. PMID: 31887632 Free PMC article.

9

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis.

Tessema M, Klinge DM, Yingling CM, Do K, Van Neste L, Belinsky SA. Tessema M, et al. Oncogene. 2010 Sep 16;29(37):5159-70. doi: 10.1038/onc.2010.255. Epub 2010 Jun 21. Oncogene. 2010. PMID: 20562917 Free PMC article.

10

Mining the epigenome for methylated genes in lung cancer.

Tessema M, Belinsky SA. Tessema M, et al. Proc Am Thorac Soc. 2008 Dec 1;5(8):806-10. doi: 10.1513/pats.200805-045TH. Proc Am Thorac Soc. 2008. PMID: 19017733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters